Clinical trial
Silencing the c-Myc Gene Using Third Generation Antisense Restenosis Therapy
NCT00777842 is registered in ClinicalTrials.gov with Cook Group Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Silencing the c-Myc Gene Using Third Generation Antisense Restenosis Therapy
- Lead sponsor
- Cook Group Incorporated
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 30, 2008
- Completion date
- December 31, 2009
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.